{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:00:00Z","timestamp":1793289600727,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejrad.2020.108889","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T08:35:38Z","timestamp":1581496538000},"page":"108889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area"],"prefix":"10.1016","volume":"125","author":[{"given":"Anton","family":"Faron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alois M.","family":"Sprinkart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus C.","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.R.","family":"Kuetting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Fimmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Attenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian A.","family":"Luetkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"94","key":"10.1016\/j.ejrad.2020.108889_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: globocan 2000","author":"Maxwell Parkin","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"27","key":"10.1016\/j.ejrad.2020.108889_bib0010","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005","author":"Altekruse","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2020.108889_bib0015","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","article-title":"Rising incidence of hepatocellular carcinoma in the United States","volume":"340","author":"El Serag","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2020.108889_bib0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"Llovet","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2020.108889_bib0025","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00259-017-3792-3","article-title":"Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection","volume":"44","author":"Ali","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2020.108889_bib0030","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.2147\/OTT.S137519","article-title":"Yttrium-90 radioembolization of unresectable hepatocellular Carcinoma \u2013 A single center experience","volume":"10","author":"Meyer","year":"2017","journal-title":"Onco. Ther."},{"key":"10.1016\/j.ejrad.2020.108889_bib0035","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00259-017-3646-z","article-title":"Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients","volume":"44","author":"Paprottka","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ejrad.2020.108889_bib0040","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology."},{"key":"10.1016\/j.ejrad.2020.108889_bib0045","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1148\/radiol.2018170408","article-title":"Diffusion-weighted MRI is superior to PET \/ CT in predicting survival of patients undergoing Y radioembolization of hepatic metastases","volume":"288","author":"Barabasch","year":"2018","journal-title":"Radiology."},{"key":"10.1016\/j.ejrad.2020.108889_bib0050","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00432-017-2395-5","article-title":"Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization","volume":"143","author":"Schmeel","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2020.108889_bib0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ageing\/afu115","article-title":"Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)","volume":"43","author":"Cruz-Jentoft","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/j.ejrad.2020.108889_bib0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejrad.2020.108889_bib0065","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2020.108889_bib0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: european consensus on definition and diagnosis","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.ejrad.2020.108889_bib0075","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/2050640618781188","article-title":"Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment","volume":"6","author":"Antonelli","year":"2018","journal-title":"United Eur Gastroenterol J."},{"key":"10.1016\/j.ejrad.2020.108889_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000484950","article-title":"Association between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"7","author":"Chang","year":"2017","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejrad.2020.108889_bib0085","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/SLA.0000000000000743","article-title":"Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma","volume":"261","author":"Voron","year":"2015","journal-title":"Ann. Surg."},{"issue":"212","key":"10.1016\/j.ejrad.2020.108889_bib0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST(mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejrad.2020.108889_bib0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jcsm.12268","article-title":"Pitfalls in the measurement of muscle mass: a need for a reference standard","volume":"9","author":"Buckinx","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.ejrad.2020.108889_bib0100","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1007\/s00330-018-5976-z","article-title":"Fat-free muscle area measured by magnetic resonance imaging predicts overall survival of patients undergoing radioembolization of colorectal cancer liver metastases","volume":"29","author":"Faron","year":"2019","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2020.108889_bib0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.semnuclmed.2009.11.001","article-title":"Radioembolization of liver tumors with Yttrium-90 microspheres","volume":"40","author":"Ahmadzadehfar","year":"2010","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.ejrad.2020.108889_bib0110","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.29602","article-title":"Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis","volume":"67","author":"Praktiknjo","year":"2018","journal-title":"Hepatology."},{"key":"10.1016\/j.ejrad.2020.108889_bib0115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13244-015-0414-0","article-title":"Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome","volume":"6","author":"Yip","year":"2015","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejrad.2020.108889_bib0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1148\/radiol.14140690","article-title":"Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging\u2014a systematic review and meta-analysis","volume":"275","author":"Lee","year":"2015","journal-title":"Radiology."},{"key":"10.1016\/j.ejrad.2020.108889_bib0125","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00261-019-01912-9","article-title":"Quantification of fat and skeletal muscle tissue at abdominal computed tomography: associations between single-slice measurements and total compartment volumes","volume":"44","author":"Faron","year":"2019","journal-title":"Abdom. Radiol. (NY)"},{"key":"10.1016\/j.ejrad.2020.108889_bib0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jvir.2009.09.011","article-title":"Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival","volume":"21","author":"Dunfee","year":"2010","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.ejrad.2020.108889_bib0135","first-page":"305","article-title":"Evaluation of Liver Biomarkers as Prognostic Factors for Outcomes to Yttrium-90 Radioembolization of Primary and Secondary Liver Malignancies","volume":"30","author":"Henrie","year":"2015","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.ejrad.2020.108889_bib0140","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1148\/radiol.2018181494","article-title":"Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in At-Risk patients","volume":"289","author":"Chernyak","year":"2018","journal-title":"Radiology."},{"key":"10.1016\/j.ejrad.2020.108889_bib0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/CIRCULATIONAHA.119.042927","article-title":"Opportunistic computed tomography imaging for the assessment of fatty muscle fraction predicts outcome in patients undergoing transcatheter aortic valve replacement","volume":"141","author":"Luetkens","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.ejrad.2020.108889_bib0150","doi-asserted-by":"crossref","unstructured":"Grimm A, Meyer H, Nickel MD, et al. A comparison between 6-point DIXON MRI and MR spectroscopy to quantify muscle fat in the thigh of subjects with sarcopenia. J Frailty Aging;8:21-26.","DOI":"10.14283\/jfa.2018.16"},{"key":"10.1016\/j.ejrad.2020.108889_bib0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1148\/radiology.153.1.6089263","article-title":"Simple proton spectroscopic imaging","volume":"153","author":"Dixon","year":"1984","journal-title":"Radiology."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X20300784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X20300784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:15:55Z","timestamp":1759994155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X20300784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":31,"alternative-id":["S0720048X20300784"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2020.108889","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2020.108889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108889"}}